๐Ÿ’Š LifeLine Medications

No one should choose between food and insulin.


๐Ÿ“Š Initiative Launch Status

CategoryStatusDetails
Overallโšช FUTURERequires pharmacy partnerships + legal framework

Prerequisites for Launch

1. Leadership

RoleStatusAction
Crown (Apothecary Guardian)๐ŸŸก InvitedAlex Oshmyansky โ€” awaiting response
Operations Lead๐Ÿ”ด OpenApply โ†’
Pharmacy Partnerships๐Ÿ”ด CriticalNeed licensed pharmacy network

2. Cold-Start Funding

SourceStatusAmount
A. Cross-Initiative (20% split via 1/3 rule)โšช PendingRequires other initiatives operational
B. Subsidy Fund๐Ÿ”ด Not StartedMember contributions for those who can’t pay
C. Seed Contributionโšช BlockedAwaiting partnership framework

3. Resource Allocation

ResourceNeedHaveGap
Licensed pharmacy partnershipsโœ…๐Ÿ”ดCritical blocker
Cold chain logisticsโœ…๐Ÿ”ดFor biologics (insulin)
Manufacturer relationshipsโœ…๐Ÿ”ดNeeds negotiation
Cross-border legal frameworkโœ…๐Ÿ”ดComplex compliance
Subsidy fund managementโœ…๐ŸŸก 50%Basic design ready

4. Technical Support Services

ServiceStatus
Platform infrastructureโœ… Ready
Payment processingโœ… Ready
Medication ordering system๐Ÿ”ด Not started
Safety compliance tracking๐Ÿ”ด Not started

Want to help launch LifeLine Medications? Get involved โ†’


What Is It?

LifeLine Medications provides affordable access to prescription medications through cooperative purchasing, cross-border coordination (where legal), and manufacturer negotiation.

The Problem

  • Insulin costs $300+/vial in the US
  • Same insulin costs $30 in Canada
  • People ration life-saving medications
  • People die because they can’t afford treatment

How It Works

  1. Cooperative purchasing pools demand for better prices
  2. Manufacturer relationships negotiate direct
  3. Cross-border access where legal and safe
  4. Subsidy fund helps those who can’t afford any cost

Safety First

  • Legitimate medications only
  • Proper cold chain for biologics
  • Licensed pharmacy partnerships
  • No compromises on quality

Cost + 20%

We take 20% margin to sustain the service. No more.

Crown Leadership

Alex Oshmyansky โ€” Apothecary Guardian

Founder of Civica Rx, the nonprofit generic drug company that makes insulin for $30/vial (vs. $300+). Also co-founded Mark Cuban Cost Plus Drugs. He’s already proven this model works.

“The problem isn’t that cheap drugs are impossible. The problem is that expensive drugs are profitable.”

Get Involved

This initiative launches with the platform. Join the waitlist โ†’


“If it works for toys, it works for insulin.”